Overall, these results demonstrate that i-PCSK9 protected endothelium in sepsis via SIRT4, indicating this epigenetic modulator as a possible innovative target against endothelial dysfunction induced by sepsis. Here, PCSK9 is linked to endothelial dysfunction.